Although less common than influenza A, influenza B infections can cause significant mortality and morbidity in children who are immunocomprised and have underlying medical conditions. We report a preterm neonate with fatal influenza B virus pneumonia. This infant presented with signs and symptoms indistinguishable from any other cause of sepsis.
Introduction
Influenza viruses are highly contagious single-stranded RNA viruses, causing acute respiratory infections that can lead to respiratory and non-respiratory complications especially in patients who are immunocomprised. 1 In children, morbidity and mortality due to influenza is highest in infants less than 6 months old. 2 Presently, no influenza vaccine or antiviral is licensed for this age group who are dependent on maternal antibodies for protection. Importantly, preterm infants may lack maternal antibodies, putting them at higher risk for acquiring influenza infections. 2 While there are several reports of influenza A infection in neonates, [3] [4] [5] [6] to our knowledge there is only one published report of influenza B in a preterm neonate. 7 We report a preterm neonate, one of twins, who developed fatal influenza B pneumonia.
Case
A 1300 g baby boy, the second of diamniotic monochorionic twins, was born at 30 weeks gestation to a 34 years old primigravida by cesarean section. Initial chest radiographs were suggestive of respiratory distress syndrome requiring one dose of surfactant and 24 h of assisted ventilation. A sepsis workup at 12 days of age for lethargy, frequent apneas and feeding intolerance showed the C-reactive protein (CRP) to be 22 mg/l (normal <8 mg/l). Blood culture was positive for coagulase-negative staphylococcus. Following 48 h of vancomycin, the baby stabilized.
At 17 days of age, persistent and severe apneas necessitated intubation and assisted ventilation. He was afebrile. Repeat blood cultures and cerebrospinal fluid examination were negative. CRP was 8 mg/l. The complete blood count showed a normal neutrophil count with an immature to total (IT) ratio of 0.23 and a normal platelet count. The chest X-ray showed bilateral opacification with proximal air bronchograms. A third generation cephalosporin was added to vancomycin. Two days later, the chest X-ray showed diffuse interstitial opacities more pronounced on the right side, requiring increasing ventilatory support. He developed metabolic acidosis requiring tromethamine infusions and hypotension refractory to inotropes but responsive to hydrocortisone. An echocardiogram showed a structurally normal heart with good function. Use of high frequency ventilation and nitric oxide resulted in transient improvement. Nucleic acid testing (NAT) on tracheal aspirate was positive for influenza B, and negative for influenza A, respiratory syncytial virus, parainfluenza (groups 1 to 4), adenovirus and human metapneumovirus. Chlamydia and ureaplasma cultures were also negative.
The baby was placed in isolation but despite maximal support, continued to deteriorate. CRP increased to 33 mg/l, platelets decreased to 50 000/cu.mm; and liver enzymes became elevated with ALT 149 U/l (normal 1-35), AST 128 U/l (normal 10-65) and g-GT 456 U/l (normal 11-63). On day 31 of life, he developed pulmonary interstitial emphysema and bilateral pneumothoraces needing multiple chest tubes. A tracheal aspirate culture, taken 2 weeks after the first, still showed influenza B which was later subtyped as B/Shanghai/361/02 by the National Microbiology Laboratory, Winnipeg.
Despite maximum ventilatory support, the baby continued to have severe hypoxia and lactic acidosis. Further treatment was withdrawn and the baby died on day 38 of life. Parents gave consent for autopsy. The other twin, after initial treatment for respiratory distress syndrome, had an uneventful stay in the NICU and was discharged home.
On autopsy, the external surfaces of the lungs were hemorrhagic with small bullae. The trachea was covered with mucoid material and most of the alveoli were collapsed. Alveoli had infiltration of macrophages and foci of hemosiderin deposits with patchy lymphocytic infiltration. Terminal bronchioli showed evidence of squamous metaplasia, fibrosis and presence of amorphous eosinophilic material. Some of these changes could be attributed to mechanical ventilation. Meningoencephalitis and myocarditis have been described in fatal cases of influenza in children 8 but were not noted in our patient. There was no intraventricular hemorrhage or periventricular leukomalacia as described by Dungen et al., 7 nor did we see adrenal atrophy as described by Troendle et al.
9

Discussion
The prevalence of influenza B in neonates is unknown. Dungen et al.
7 described a 29-week gestation male infant who died with influenza B pneumonia. This patient, like ours, developed Staphylococcus epidermidis sepsis before contracting influenza B. Whether staphylococcus infection predisposes neonates to influenza is presently unknown. Liou et al. 4 described 24 children with influenza B infection, all were less than 3 years old and included a 34-week gestation female who died at 3 months of age with respiratory failure. Troendle et al. 9 described a term female infant with Turner's syndrome who died of influenza B infection acquired at 40 days of age. Weigel et al. 10 reported a patient with influenza B who was between 32 and 36 weeks of gestation, although the age at which the infection was acquired was not given. Twin pregnancy has been described as a risk factor for influenza infection in neonates. 6 Clinical symptoms of influenza in neonates are non-specific and can be indistinguishable from other causes of sepsis. 1 Our patient presented with apneic spells, similar to five neonates with influenza A described by Meibalane et al. 5 The preterm patient described by Dungen et al. 7 had severe respiratory distress. Fever, cough and coryza have been described with influenza A in neonates. 3 Older infants with both influenza A and B can present with similar symptoms. 1 Although not seen in our patient, seizures have been described with both influenza A and B in neonates. 7, 11 The peripheral white cell count in influenza infection can be variable with normal counts, leucocytosis and leucopenia being all described. 7, 11 Our patient had a normal total neutrophil count with a mildly elevated IT ratio. Although the platelet count decreased to 50 000/cu.mm, thrombocytopenia is an uncommon finding in influenza infections in children.
11 CRP levels, initially normal, later became elevated. However, elevated CRP levels have been described with influenza infections 7, 12 in neonates, making this a poor marker for differentiation from bacterial infections. Chest radiographs showed consolidation and air bronchograms suggestive of a bacterial infection and later, an interstitial pattern, suggestive of viral pneumonitis. 7, 12 As in our patient, Dungen et al. 7 also described interstitial emphysema and pneumothoraces in their patient.
A definitive diagnosis of influenza requires laboratory confirmation. NAT, whether by nucleic acid sequence base amplification (NASBA) or PCR, is significantly more sensitive than either fluorescent antibody or culture or both. 13, 14 NASBA is an alternative method to reverse transcriptase PCR to detect ribonucleic acid targets. The amplification step is isothermal, unlike traditional PCR. At our facility, NASBA is routinely used to detect both influenza A and B in respiratory samples using the probes and primers described by Moore et al. 15 The advantage of rapid diagnostic tests for influenza is the implementation of infection control measures in a timely manner, and in older children, the early institution of antiviral treatment avoiding unnecessary antibiotics. 3, 11 No other neonate in our neonatal intensive care unit (NICU) developed symptoms of influenza and did not need isolation. Our patient was not placed on any antiviral medication.
Influenza B virus is transmitted by inhalation of infectious droplets or direct contact with fomites from infected persons. In the NICU, the source of the virus is either infected NICU personnel or visitors, including parents. The incubation period is 1 to 4 days. Virus shedding is maximal during the first 3 days of the illness and lasts for about 7 days but, like in our patient, can be much longer in young infants. 1 The father had upper respiratory symptoms and could have been the source of infection. During this period, influenza activity in Alberta and the Calgary Health Region (K Fonseca, personal communication) was primarily due to influenza A with sporadic cases of influenza B, B/Shanghai/ 361/02 subtype. 16 Local epidemiologic data should be taken into account when considering influenza as a cause of illness in the NICU. Given the severity of influenza B in neonates and the lack of any specific antiviral treatment and vaccine in this vulnerable age group every effort should be made to prevent transmission of infection. The importance of screening and keeping NICU personnel and visitors, including parents, with any respiratory illness away from the NICU cannot be overemphasized. 3, 5 The risk of transmission can be further reduced by encouraging influenza immunization of NICU personnel and other caregivers including parents. 7, 11, 17 Maternal influenza immunization during pregnancy is another way of protecting neonates against influenza resulting in higher levels of vaccine specific immunoglobulin G antibodies in the newborn. 2 However, preterm infants may not receive sufficient quantities of protective antibodies. The current recommendation is that women who are pregnant during the influenza season should receive the trivalent influenza vaccine (TIV) during autumn.
1 TIV is not a live virus vaccine and is considered safe during pregnancy. 2 Immunization during pregnancy is considered to be the single most important factor in decreasing hospitalizations due to influenza in children less than a year old. However, current maternal immunization rates are poor. 2 Fatal influenza B virus pneumonia K Yusuf et al
